ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
First Patient Dosed with DNA-based, Neoantigen-Targeting Personalized Vaccine from Geneos
July 12, 2019Geneos Therapeutics, a clinical-stage biotech company, a spin-out of Inovio Pharmaceuticals, announced the first cancer patient was dosed using the company's GT-EPIC Neoantigen-Targeting Personalized Vaccine Technology. -
New personalized vaccines promise to keep cancer at bay
July 10, 2017Personalized cancer vaccines, tailored to the tumors of individual patients, kept disease in check in two early-stage clinical trials
Pharma Sources Insight January 2025
